Valuation: Bonesupport Holding AB

Market Cap 16.78B 1.68B 1.5B 1.4B 1.27B 2.39B 159B 2.43B 6.56B 83.2B 6.32B 6.18B 266B P/E 2026 *
52.5x
P/E 2027 * 33.2x
Enterprise Value 16.23B 1.63B 1.45B 1.35B 1.23B 2.31B 154B 2.35B 6.35B 80.5B 6.11B 5.98B 258B EV / Sales 2026 *
10.8x
EV / Sales 2027 * 7.96x
Free-Float
89.54%
Yield 2026 *
0.57%
Yield 2027 * 0.85%
1 day+1.10%
1 week+11.29%
Current month+12.57%
1 month+18.28%
3 months+16.77%
6 months-0.93%
Current year+36.28%
1 week 238.2
Extreme 238.2
258.8
1 month 205.8
Extreme 205.8
258.8
Current year 165
Extreme 165
273.2
1 year 165
Extreme 165
273.2
3 years 110.2
Extreme 110.2
405.8
5 years 34.2
Extreme 34.2
405.8
10 years 9.04
Extreme 9.04
405.8
Manager TitleAgeSince
Chief Executive Officer 49 31/08/2025
Director of Finance/CFO 63 31/10/2018
Chief Operating Officer 51 30/11/2021
Director TitleAgeSince
Director/Board Member 68 31/12/2009
Chairman 70 14/12/2016
Chairman 71 13/05/2019
Date Insider Type Main position Quantity % Market Cap. Importance
28/08/26 Buy

Public Communications Manager

170 0.0003%
26/08/26 Buy

Director

30 0.0000%
20/07/26 Buy

Chief Executive Officer

1,950 0.0030%
Change 5-day change 1-year change 3-year change Capi.($)
+1.10%+11.29%-3.03%+116.57% 1.65B
+3.55%+7.01%+51.42%+105.45% 1,077B
-0.25%-1.25%+32.49%+61.48% 612B
+0.59%+4.03%+25.28%+91.54% 501B
-1.48%+1.97%+72.62%+39.59% 364B
+2.37%+7.66%+33.65%+48.87% 353B
+2.64%+6.95%+21.01%+43.85% 278B
+3.24%+6.78%+0.43%+15.71% 251B
+1.86%+6.53%+45.98%+52.77% 230B
+2.49%+6.98%+33.03%+102.67% 190B
Average +1.61%+5.20%+31.29%+67.85% 385.82B
Weighted average by Cap. +1.74%+4.12%+38.63%+71.74%

Financials

2026 *2027 *
Net sales 1.51B 151M 135M 125M 114M 215M 14.32B 218M 589M 7.47B 567M 555M 23.9B 2B 201M 179M 167M 152M 285M 19.02B 290M 783M 9.93B 754M 738M 31.76B
Net income 324M 32.51M 29.02M 26.97M 24.53M 46.16M 3.08B 46.99M 127M 1.61B 122M 119M 5.14B 511M 51.24M 45.74M 42.51M 38.67M 72.75M 4.85B 74.06M 200M 2.53B 192M 188M 8.1B
Net Debt -545M -54.66M -48.79M -45.34M -41.24M -77.59M -5.18B -78.99M -213M -2.7B -205M -201M -8.64B -855M -85.79M -76.57M -71.17M -64.73M -122M -8.13B -124M -334M -4.24B -322M -315M -13.57B
Projected Income Statement - Annual - Bonesupport Holding AB
Logo Bonesupport Holding AB
Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.
Employees
171
Date Price Change Volume
15/10/26 SEK 256.20 +1.10% 175,044
14/10/26 SEK 253.40 +1.69% 203,086
13/10/26 SEK 249.20 +2.72% 511,801
12/10/26 SEK 242.60 +2.28% 232,629
09/10/26 SEK 237.20 +3.04% 286,951
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Bonesupport Holding AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
256.20SEK
Average target price
357.42SEK
Spread / Average Target
+39.51%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bonesupport Holding AB
  1. Stock Market
  2. Stocks
  3. BONEX Stock